We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




siRNA Design Criteria and Validation Data

By Biotechdaily staff writers
Posted on 12 Feb 2004
Eight previously undisclosed small interfering RNA (siRNA) design criteria along with the data validating their functionality in gene silencing have been published in a scientific paper appearing in the February 1, 2004, online issue of Nature Biotechnology.

The design criteria were developed by Dharmacon, Inc. More...
(Lafayette, CO, USA), which has employed rational methods for siRNA design since 2002. The basis for this rational design was extended to a total of 25 criteria forming the foundation of the company's Smartselection technology platform. Smartselection design significantly enhances the probability of efficient silencing and provides a high degree of potency and specificity. Dharmacon is making all eight of the disclosed criteria available through its online siRNA design tool, siDesign Center.

In the published paper, Dharmacon scientists identify eight criteria associated with siRNA by performing a systematic analysis of a large set of siRNAs targeting multiple genes. Each individual criterion alone is not sufficient to ensure gene silencing, but incorporating all eight into a single multi-component algorithm was over 96% effective in predicting functional siRNAs. The criteria include internal thermodynamic stability, a lack of internal repeats, and positional sequence-specific determinants.


"We felt it was time to elevate the current standard of publicly available design tools by making the eight criteria available to the scientific community through our free online siDesign Center siRNA design tool,” said Stephan A. Scaringe, Ph.D., co-chairman and chief scientific officer of Dharmacon.




Related Links:
Dharmacon

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.